Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinibAilin Guo, Y. Lynn Wang|Oncotarget|2015Cited by 55
Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironmentAilin Guo, Y. Lynn Wang|Oncotarget|2017Cited by 51